Docebo files Q2 2025 results on Form 6-K

Docebo Inc. submitted a Form 6-K as a foreign private issuer, mainly to furnish its second-quarter 2025 reporting package.

Accepted by SEC EDGAR 08/08/2025 - 07:12 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Docebo Inc. submitted a Form 6-K as a foreign private issuer, mainly to furnish its second-quarter 2025 reporting package. The filing includes unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the three and six months ended June 30, 2025.

It also attaches a press release dated August 8, 2025 titled “Docebo Reports Second Quarter 2025 Results,” CEO and CFO interim filing certificates required under Canadian regulations, and full Inline XBRL data files, providing structured financial information for electronic analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Docebo Inc. (DCBO) report in its August 2025 Form 6-K?

Docebo Inc. files a Form 6-K to furnish its second-quarter 2025 reporting package, including unaudited interim financial statements, management’s discussion and analysis, a Q2 results press release, Canadian CEO/CFO certificates, and accompanying Inline XBRL data files.

Which financial periods are covered by Docebo Inc.’s Q2 2025 Form 6-K?

The Form 6-K covers unaudited condensed consolidated interim financial statements and MD&A for Docebo Inc. for the three and six months ended June 30, 2025, giving investors insight into both the quarterly and year-to-date financial position and operating performance.

What key exhibits are included in Docebo (DCBO) Q2 2025 Form 6-K?

Key exhibits include unaudited interim financial statements, management’s discussion and analysis for the three and six months ended June 30, 2025, a press release dated August 8, 2025 titled “Docebo Reports Second Quarter 2025 Results,” and CEO and CFO interim filing certificates under Canadian regulations.

How does Docebo Inc. support electronic analysis in its Q2 2025 filing?

Docebo Inc. includes multiple Inline XBRL exhibits, such as the instance document, taxonomy schema, calculation, definition, label, and presentation linkbases, plus a cover page interactive data file, enabling automated extraction and analysis of its Q2 2025 financial information.

Are Docebo Inc.’s Q2 2025 interim financial statements audited?

The interim financial statements furnished in this Form 6-K are explicitly described as unaudited condensed consolidated interim financial statements, covering the financial position and results for the three and six months ended June 30, 2025, which is typical for quarterly reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number 001-39750

DOCEBO INC.

(Exact name of Registrant as specified in its charter)

N/A

(Translation of Registrant’s name)

366 Adelaide St. West

Suite 701

Toronto, Ontario, Canada M5V 1R7

(800) 681-4601

(Address and telephone number of registrant’s principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☐ Form 40-F ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

INCORPORATION BY REFERENCE

Exhibits 99.1, 99.2, 99.4 and 99.5 of this Form 6-K are incorporated by reference to the registrant's Registration Statement on Form F-10 (File No. 333-251046), the registrant’s Registration Statement on Form S-8 (File No. 333-251417) and the registrant’s Registration Statement on Form F-3 (File No. 333-262000).

DOCUMENTS INCLUDED AS PART OF THIS REPORT

Exhibit
99.1			Unaudited Condensed Consolidated Interim Financial Statements of Financial Position of the Registrant for the Three and Six Months Ended June 30, 2025
99.2			Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Registrant for the Three and Six Months Ended June 30, 2025
99.3			Press Release of Docebo Inc., dated August 8, 2025, titled “Docebo Reports Second Quarter 2025 Results”
99.4			Docebo Inc. – Form 52-109F2 Certificate of Interim Filings by CEO (pursuant to Canadian regulations)
99.5			Docebo Inc. – Form 52-109F2 Certificate of Interim Filings by CFO (pursuant to Canadian regulations)
101.INS			Inline XBRL Instance Document.
101.SCH			Inline XBRL Taxonomy Schema Linkbase Document.
101.CAL			Inline XBRL Taxonomy Calculation Linkbase Document.
101.DEF			Inline XBRL Taxonomy Definition Linkbase Document.
101.LAB			Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE			Inline XBRL Taxonomy Presentation Linkbase Document.
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Docebo Inc.

Date:

August 8, 2025

By:

/s/ Brandon Farber

Name:

Brandon Farber

Title:

Chief Financial Officer